Hyaluronic Acid (HA) has become one of the most prevalent active ingredients in cosmeceutical product development and used for its hydrating, anti-aging, and healing features. As society increasingly demands science-based, transparent, and sustainable skincare formulations, the regulatory framework is central to the growth of the HA-based dermaceutical product development market. Compliance is an essential legal activity, but also an element of consumer trust. [1]

Regulatory and Compliance Aspects in Hyaluronic Acid-Enhanced Cosmeceuticals

Consumer & Market Research Sept 06, 2025

Hyaluronic Acid (HA) has become one of the most prevalent active ingredients in cosmeceutical product development and used for its hydrating, anti-aging, and healing features. As society increasingly demands science-based, transparent, and sustainable skincare formulations, the regulatory framework is central to the growth of the HA-based dermaceutical product development market.  Compliance is an essential legal activity, but also an element of consumer trust. [1]

Regulatory Issues Related to HA Cosmeceuticals

Ingredient Disclosure and Clean Labels

  • Regulatory Reference: The European Commission (EC), Regulation No 1223/2009.

 REGULATORY THRESHOLDS:

  • Cosmetic ingredients must be labelled appropriately.
  • All hyaluronic acid (HA) must indicate molecular weight, source (biosynthetic, plant or animal), and concentration.
  • Not include false claims.

 IMPACT: Supports compliance and builds consumer trust for informed users interested in cosmeceutical ingredient development and formulation. [2]

Good Manufacturing Practices (GMP)

Guidelines Reference: ISO 22716 (GMP Guidelines for Cosmetics).

 POINTS OF INTEREST:

  • To create consistency in the production of the product, to maintain the integrity of the product.
  • Stability and consistency of HA formulations.
  • Minimize contamination.
  • Efficacy is consistent across batches produced.

Market Reference: GMP certification is not generally a requirement to enter the market for compliance in the EU or in the US.

Sustainability and Environmental Regulatory Issues

Ethical Sourcing of HA – ideally, HA from a synthesized process (microbial fermentation process). Ideally, no HA from animal-derived sources is preferred.

REGULATORY SUPPORT:

  • Eco-friendly packaging i.e. biodegradable, recyclable, refillable.
  • Measures to reduce carbon footprint – lifecycle assessment.

 EXAMPLE: EU Green Deal and Circular Economy Action Plan drive sustainability compliance, aligning with ethical cosmeceutical product development practices.

Claims and Clinical Trials

References for Regulation:

  • EC No 655/2013 (Advantages of Claims – Common Criteria across the EU
  • FDA based principles for “truth in labeling” (USA).

Regulation Expectations:

  • We are expected to have a scientific basis for claims of “anti-wrinkle”, “hydration”, or “skin rejuvenation”.
  • Clinical evidence must evidence validation (randomized controlled clinical trial, or consumer use study).

Global Regulatory Environment

United States – FDA regulations

  • Regulated under the Federal Food, Drug, and Cosmetic Act (FD&C Act)
  • No pre-approval for cosmetics
  • HA-based products making structure/function claims can be considered drugs → require additional compliance and FDA approval.
  • Marketing claims must be carefully framed so that they are not classified as drugs.
  • Ingredient safety must be supported through toxicological evaluations. [4]

Europe – Regulation EC No 1223/2009

  • EU applies the strictest cosmetic regulations in the world.

Requirements include:

  • Safety assessments.

Product Information File (PIF).

  • Product registration under Cosmetic Products Notification Portal (CPNP) prior to launch.

HA-cosmeceutical requirement includes:

  • Claims validation.
  • Limitations on preservatives and additives.
  • Sustainability and environmental safety parameters.[5]
Regulatory and Compliance Aspects in Hyaluronic Acid thumbnail

Regulatory Frameworks in the Asia-Pacific region

China – CSAR (Cosmetic Supervision and Administration Regulation)

  • Registration or filing is required depending on the product.
  • Animal testing is required (although there are many exemptions).
  • Consumer inclination is towards more innovative circumstances.[6]

 

Japan – Pharmaceutical and Medical Device Act (PMD Act)

HA-based cosmetics are classified as:

  • Quasi-drugs (disinfestation future, requiring approval of some functional claims).
  • Cosmetics (not as strenuous pathway). [7]

 

South Korea – Korea Food and Drug Administration (KFDA)

Functional cosmetics are a special category.

Clinical data is mandatory to substantiate consumer assessments for claims such as:

o            Decrease in wrinkle formation.

o            Improvements in skin hydration.

Use of HA in Cosmetic Product Formats

Hyaluronic acid is used in a variety of cosmetic formats that require different concentrations of HA to achieve the best result for the cosmetic application.

For example, serums can have a higher concentration of HA (0.5–2%) in order to maximize hydration and plumping, while moisturizers will typically, have a lower concentration than serums (0.1–0.5%) for hydration across the day, whereas cleansers and sheet masks often contain HA in trace amounts (<0.1% to 0.2%), for surface area hydration or soothing.

To better understand the regulatory acceptance around HA concentrations in the various markets,

Table 1 sets out product specific concentration ranges, as well as a summary of key regulatory positions between the EU, US and Asian markets. This allows formulators, as well as regulation stakeholders, to have a concise reference to be market-ready and compliant. [8]

 

Table 1. Regulatory Comparison of HA Concentrations in Cosmetic Products

Product Type

Example Product

HA Concentration

Regulatory Notes

Serums

The Ordinary Hyaluronic Acid 2% + B5

2%

EU, US, and Asia: Permitted; safety supported up to 2%

Moisturizers

Neutrogena Hydro Boost Water Gel

0.2–0.5%

Widely accepted in EU, US, and Asia; claims of hydration substantiated

Sheet Masks

Dr.Jart+ Vital Hydra Solution Mask

0.1–0.3%

Functional cosmetic claims in Korea require clinical support; EU and US accepted

Cleansers

La Roche-Posay Toleriane Hydrating Gentle Cleanser

<0.1%

Used for topical hydration; no restriction on concentration

Eye Creams

Kiehl’s Creamy Eye Treatment with Avocado

0.1–0.3%

HA concentration typical for hydration; claims must be supported

Injectables (Dermal Fillers)

Juvederm Voluma XC

20 mg/mL

Classified as medical device in EU/Asia; FDA-approved dermal filler in US

 

Product Example:

Product Name: The Ordinary

Product Type: Serum

The significance of ethical & sustainable compliance

Modern consumers are increasingly using ethics to evaluate brands. There is considerable value in compliance with sustainability frameworks such as reducing animal testing, cruelty-free certifications, and switching to renewable HA sources, as this adds to brand equity, and the company has demonstrated a commitment to responsible production practices by complying with an international standard like ISO 14001-Environmental Management Systems. Think of E-regulatory compliance as ‘ethics compliant’; consumers expect companies to meet ethical practices as a baseline for socially responsible corporate behaviour.

Future Regulatory Trends

We predict the regulatory landscape for HA-infused cosmeceuticals will become more stringent as consumer expectations rise. Our key future trends warrant your attention:

  • An increasing responsibility to provide data transparency, including creating a digital product passport and QR-based labelling.
  • Increase in sustainability regulations, including bills for extended producer responsibility (EPR) of packaging waste.
  • Product claims facing greater scrutiny and expectations, particularly in regard to more rigorous clinical validation in marketing for multifunctional or custom/personalized skincare products.
  • Global harmonizing, including the collaboration between regulatory bodies across the EU, US and Asia-Pacific to streamline cross-border trade.

These trends suggest compliance is always changing, and forced brands to react after regulations change does not lend itself well to compliance. Being compliant means anticipating compliance and expectations for the future.

Conclusion

Creating and commercializing HA-based cosmeceuticals is a complex process requiring attention to safety, transparency, and sustainability. From ingredient disclosure to GMP compliance, sourcing, and clinical validation, global standards leave no shortcuts. Brands embracing ethical compliance and sustainability gain competitive advantage in dermaceutical product development and anti-aging cosmeceutical product design. Specialized R&D partners like Food Research Lab assist in cosmeceutical product development, formulation, and regulatory compliance (EU, US, Asia-Pacific), ensuring market-ready products that meet global consumer expectations.